Literature DB >> 10446904

Role of the rate of internalization of the agonist-receptor complex on the agonist-induced down-regulation of the lutropin/choriogonadotropin receptor.

K Nakamura1, M F Lazari, S Li, C Korgaonkar, M Ascoli.   

Abstract

The extent of agonist-induced down-regulation of the LH/CG receptor (LHR) in human kidney 293 cells transfected with the rat LHR (rLHR) is much lower than in two Leydig tumor cell lines (MA-10 and R2C) that express the rodent LHR endogenously. This difference can not be attributed to differences in the recycling of internalized receptors, or in the replenishment of new receptors at the cell surface. It can be correlated, however, with the half-life of internalization of the bound agonist, which is approximately 60 min in Leydig tumor cells and about 100 min in transfected 293 cells. To determine whether the rate of internalization of the bound agonist affects down-regulation, we compared these two parameters in 293 cells expressing four rLHR mutants that enhance internalization and three mutants that impair internalization. We show that all four mutations of the rLHR that enhanced internalization enhanced down-regulation, while only one of the three mutations that impaired internalization impaired down-regulation. In addition, cotransfections of 293 cells with the rLHR-wt and three constructs that enhanced internalization (G protein-coupled receptor kinase 2, beta-arrestin, and arrestin-3) increased down-regulation, while a related construct (visual arrestin) that had no effect on internalization also had no effect on down-regulation. We conclude that the rate of internalization of the agonist-LHR complex is the main determinant of the extent of down-regulation of the LHR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446904     DOI: 10.1210/mend.13.8.0331

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  6 in total

1.  Characterization of relaxin receptor (RXFP1) desensitization and internalization in primary human decidual cells and RXFP1-transfected HEK293 cells.

Authors:  András Kern; Gillian D Bryant-Greenwood
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

2.  A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation.

Authors:  Colette Galet; Mario Ascoli
Journal:  Mol Endocrinol       Date:  2006-06-27

3.  Assessing Gonadotropin Receptor Function by Resonance Energy Transfer-Based Assays.

Authors:  Mohammed Akli Ayoub; Flavie Landomiel; Nathalie Gallay; Gwenhael Jégot; Anne Poupon; Pascale Crépieux; Eric Reiter
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-27       Impact factor: 5.555

4.  Human Luteinizing Hormone and Chorionic Gonadotropin Display Biased Agonism at the LH and LH/CG Receptors.

Authors:  Laura Riccetti; Romain Yvinec; Danièle Klett; Nathalie Gallay; Yves Combarnous; Eric Reiter; Manuela Simoni; Livio Casarini; Mohammed Akli Ayoub
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

5.  The Effects of Separate and Combined Treatment of Male Rats with Type 2 Diabetes with Metformin and Orthosteric and Allosteric Agonists of Luteinizing Hormone Receptor on Steroidogenesis and Spermatogenesis.

Authors:  Andrey A Bakhtyukov; Kira V Derkach; Viktor N Sorokoumov; Anna M Stepochkina; Irina V Romanova; Irina Yu Morina; Irina O Zakharova; Liubov V Bayunova; Alexander O Shpakov
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

Review 6.  Intracellular Follicle-Stimulating Hormone Receptor Trafficking and Signaling.

Authors:  Niamh Sayers; Aylin C Hanyaloglu
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-02       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.